These results are comparable to those obtained 6–24 weeks after the administration of intravenous iron to women with moderate PPIDA (mean Hb increment, 3.8 g/dL; anemia correction, 88%; n = 658) [16–19]. The gene discussed is GSTM1; the disease is anemia.